Trends in HIV/AIDS cases in Kyrgyzstan between 2012 and 2022: An ecological study.

IF 2.8 3区 医学 Q2 INFECTIOUS DISEASES
HIV Medicine Pub Date : 2025-07-14 DOI:10.1111/hiv.70078
Iana Kirillova, Nimetcan Mehmet Orhun
{"title":"Trends in HIV/AIDS cases in Kyrgyzstan between 2012 and 2022: An ecological study.","authors":"Iana Kirillova, Nimetcan Mehmet Orhun","doi":"10.1111/hiv.70078","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>HIV/AIDS continues to exert a significant toll on health care systems and governments worldwide, including in Kyrgyzstan, impacting the health and well-being of millions. The aim of this study was to examine how the patterns of HIV transmission in Kyrgyzstan evolved between 2012 and 2022.</p><p><strong>Methods: </strong>This ecological study employed retrospective data collection. Quantitative methods were employed to assess and analyse changes in patterns of HIV transmission, as well as co-infections such as HIV + hepatitis B virus (HBV) and HIV + hepatitis C virus (HCV), across individuals with varying modes of HIV acquisition. Data encompassed all diagnosed HIV cases from 2012 to 2022 across Chui, Talas, Naryn, Issik-Kol, Batken, Osh, Jalal-Abad oblasts, Bishkek and Osh.</p><p><strong>Results: </strong>HIV incidence increased from 8.36 to 14.56 per 100 000 populations between 2013 and 2022, with the most significant rise among females, from 8.42 per 100 000 in 2020 to 11.72 per 100 000 in 2022. The study also highlighted an increase in new HIV cases via heterosexual transmission (from 71.7% in 2020 to 81.9% in 2022), and men who have sex with men (MSM)transmission (from 40 cases in 2020 to 75 cases in 2022), while transmission among people who inject drugs dropped significantly (from 201 cases in 2017 to 21 cases in 2022). Notably, there were reductions in new HIV infections through vertical transmission, medical procedures and co-infections with HIV + HBV and HIV + HCV.</p><p><strong>Conclusion: </strong>Between 2012 and 2022, HIV incidence saw a significant rise, especially among individuals aged 18-29 and 30-39 years, with a marked increase among females. The study revealed a shift in transmission modes over this period. While new infections among people who inject drugs declined, there was an uptick in cases reported among MSM and the general population in the country.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hiv.70078","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: HIV/AIDS continues to exert a significant toll on health care systems and governments worldwide, including in Kyrgyzstan, impacting the health and well-being of millions. The aim of this study was to examine how the patterns of HIV transmission in Kyrgyzstan evolved between 2012 and 2022.

Methods: This ecological study employed retrospective data collection. Quantitative methods were employed to assess and analyse changes in patterns of HIV transmission, as well as co-infections such as HIV + hepatitis B virus (HBV) and HIV + hepatitis C virus (HCV), across individuals with varying modes of HIV acquisition. Data encompassed all diagnosed HIV cases from 2012 to 2022 across Chui, Talas, Naryn, Issik-Kol, Batken, Osh, Jalal-Abad oblasts, Bishkek and Osh.

Results: HIV incidence increased from 8.36 to 14.56 per 100 000 populations between 2013 and 2022, with the most significant rise among females, from 8.42 per 100 000 in 2020 to 11.72 per 100 000 in 2022. The study also highlighted an increase in new HIV cases via heterosexual transmission (from 71.7% in 2020 to 81.9% in 2022), and men who have sex with men (MSM)transmission (from 40 cases in 2020 to 75 cases in 2022), while transmission among people who inject drugs dropped significantly (from 201 cases in 2017 to 21 cases in 2022). Notably, there were reductions in new HIV infections through vertical transmission, medical procedures and co-infections with HIV + HBV and HIV + HCV.

Conclusion: Between 2012 and 2022, HIV incidence saw a significant rise, especially among individuals aged 18-29 and 30-39 years, with a marked increase among females. The study revealed a shift in transmission modes over this period. While new infections among people who inject drugs declined, there was an uptick in cases reported among MSM and the general population in the country.

2012年至2022年吉尔吉斯斯坦艾滋病毒/艾滋病病例趋势:一项生态学研究。
背景:艾滋病毒/艾滋病继续对包括吉尔吉斯斯坦在内的世界各地的卫生保健系统和政府造成重大损失,影响着数百万人的健康和福祉。本研究的目的是研究2012年至2022年期间吉尔吉斯斯坦艾滋病毒传播模式的演变。方法:本生态研究采用回顾性资料收集。采用定量方法来评估和分析艾滋病毒传播模式的变化,以及艾滋病毒+乙型肝炎病毒(HBV)和艾滋病毒+丙型肝炎病毒(HCV)等共同感染,这些感染在不同艾滋病毒获取模式的个体中发生。数据包括2012年至2022年Chui、Talas、Naryn、isisk - kol、Batken、奥什、Jalal-Abad州、比什凯克和奥什的所有确诊艾滋病毒病例。结果:2013 - 2022年间,HIV感染率从8.36 / 10万人上升到14.56 / 10万人,其中女性感染率上升最为显著,从2020年的8.42 / 10万人上升到2022年的11.72 / 10万人。该研究还强调,通过异性恋传播的新艾滋病毒病例增加(从2020年的71.7%增加到2022年的81.9%),男男性行为者(MSM)传播(从2020年的40例增加到2022年的75例),而注射吸毒者的传播显著下降(从2017年的201例减少到2022年的21例)。值得注意的是,通过垂直传播、医疗程序以及艾滋病毒+乙型肝炎病毒和艾滋病毒+丙型肝炎病毒合并感染的新发艾滋病毒感染有所减少。结论:2012年至2022年,中国HIV感染率显著上升,尤其是18-29岁和30-39岁人群,其中女性明显上升。该研究揭示了这一时期传播模式的转变。虽然注射吸毒者中的新感染病例有所下降,但该国男同性恋者和一般人群中报告的病例有所上升。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信